Showing results (21-30 of 193) with videos related to

Sort By:
Pageof 20
Biology|January 8, 2025
Exploring Trimethylaminuria: Genetics and Molecular Mechanisms, Epidemiology, and Emerging Therapeutic StrategiesAntonina Sidoti, Rosalia D'Angelo, Andrea Castagnetti, et al.
ACS Medicinal Chemistry Letters|May 22, 2020
Pharmacophore-Based Virtual Screening for Identification of Negative Modulators of GLI1 as Potential Anticancer AgentsFabrizio Manetti, Barbara Stecca, Roberta Santini, et al.
Antiviral Research|September 9, 2015
The thioacetate-ω(γ-lactam carboxamide) HDAC inhibitor ST7612AA1 as HIV-1 latency reactivation agentRoger Badia, Judith Grau, Eva Riveira-Muñoz, et al.
Cancer Letters|June 1, 2005
Molecular mechanism of HMGA1 deregulation in human neuroblastomaGiuseppe Giannini, Fabio Cerignoli, Massimiliano Mellone, et al.
Molecular Genetics & Genomic Medicine|November 7, 2020
A novel BRCA2 splice variant identified in a young womanArianna Nicolussi, Francesca Belardinilli, Laura Ottini, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2012
Camptothecins in tumor homing via an RGD sequence mimeticDomenico Alloatti, Giuseppe Giannini, Loredana Vesci, et al.
European Journal of Medicinal Chemistry|November 20, 2019
Novel N-acetyl-Glycol-split heparin biotin-conjugates endowed with anti-heparanase activityEmiliano Esposito, Israel Vlodavsky, Uri Barash, et al.
European Journal of Medicinal Chemistry|April 19, 2014
Influence of the adamantyl moiety on the activity of biphenylacrylohydroxamic acid-based HDAC inhibitorsRaffaella Cincinelli, Loana Musso, Giuseppe Giannini, et al.
Glycobiology|January 15, 2016
Kinetic analysis and molecular modeling of the inhibition mechanism of roneparstat (SST0001) on human heparanaseDaniele Pala, Silvia Rivara, Marco Mor, et al.
Gels (Basel, Switzerland)|August 25, 2023
Tau-Marin Mucoadhesive Gel for Prevention and Treatment of Gum DiseasesGiuseppe Giannini, Irene Ragusa, Giulia Nerina Nardone, et al.
Pageof 20